 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
5/17/21 Eterna Therapeutics Inc. 10-Q 3/31/21 70:4.5M Broadridge Fin’l So… Inc
3/31/21 Eterna Therapeutics Inc. 8-K:2,3,5,8 3/25/21 9:439K Broadridge Fin’l So… Inc
| ____________ | | ¹ | Filing/Form Types: | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | 10-Q | Quarterly Report — Form 10-Q. |
|
